![]()
|
Report Date : |
31.07.2007 |
IDENTIFICATION DETAILS
|
Name : |
RESEARCH PHARMACEUTICAL LTD |
|
|
|
|
Registered Office : |
2706 Times Square - Tower |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
April 12, 2000 |
|
|
|
|
Com. Reg. No.: |
712318 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
-- |
RATING & COMMENTS
|
MIRAs Rating : |
C |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
name & address
RESEARCH PHARMACEUTICAL LTD
2706 TIMES SQUARE - TOWER
TEL : 852-28519623
FAX : 852- 25231797
EXECUTIVE SUMMARY
INCORPORATION DATE :
APRIL 12, 2000
REGISTRATION NO. :
712318
LEGAL FORM :
PRIVATE LIMITED COMPANY
CHIEF EXECUTIVE :
N/A
STAFF STRENGTH :
N/A
CAPITAL :
US$ 1,279
BUSINESS LINE :
N/A
TURNOVER :
N/A (AS OF DEC. 31, 2006)
EQUITIES :
N/A (AS OF DEC. 31, 2006)
PAYMENT :
AVERAGE
RECOMM.
MARKET CONDITION :
N/A
FINANCIAL CONDITION :
N/A
OPERATIONAL TREND : N/A
GENERAL REPUTATION : N/A
EXCHANGE RATE :
HKD 7.82137 = US$1 AS OF 2007-7-27
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
HKD
![]()
*Company Registration*
===================
(1)
License number : 712318
Date issued : 12 April,
2000
Issuing authority : Companies
Registry
Type of license : Corporate
(2)
License number : 30881351
Date issued : N/A
Issuing authority : Business
Registration Office - Inland Revenue Dept
Type of license :
Business
*Capital Details*
=============
Authorized capital: HKD 10,000.00 divided into 10,000 ordinary shares of
HKD 1.00/-each, fully paid
*Reputation*
==========
Due to the fact that the subject company:
(i) Does not maintain an
operational office in
(ii) There is no knowledge or public record of overseas business activities
It has not been possible to ascertain the reputation of the company.
![]()
SC is not known to host website of its own at present.
![]()
For the past two years there is no record of litigation.
![]()
*Major Shareholders*
=================
Total number of shareholders :
2
Total number of ordinary shares : 10,000
Shareholders' Name
No. of Ordinary Shares
Amount of Shares (HKD) % of Shares
--------------------------
-------------------------------
---------------------------------
----------------
WES CO INC
9,500
9,500.00 95.00
DIOPHRAM SA
500
500.00 5.00
*Director's Details*
===============
(1)
Jairo Alfonso Escobar Ramirez
Passport no. : CC 16627602
Address :
Zona Franca de
(2)
Cesar Orrego Echeverry
Passport no. :
CC-16764635
Address :
Zona Franca de
(3)
Susana Helena Ortega Peterson
Passport no. :
CC31281137
Address :
Zona Franca de
*Corporate Secretary*
=================
OVERSEAS COMSEC LTD
CR no. : 655275
Address : 2706 Times Square - Tower
![]()
SC declined to release its management background at present.
![]()
OPERATIONAL STATUS
=====================
The Subject Business Entity does NOT maintain an operational office at
the address listed above. The office located at the address above (including
telephone and fax numbers) is operated and managed by a firm specializing in
Corporate Secretarial /
The name of the Corporate Secretarial /
OVERSEAS COMSEC LTD
*Operations Status*
================
Although the subject is a legally registered entity, it does not
maintain an operational office, nor any employees in this country, but rather
employs the services of a local firm engaged in corporate secretarial management
services to maintain their license on behalf of the owners who are located
overseas.
The management services usually involves registering the office address
as the same one used by the firm employed to maintain the license, as well as
receive any mail address to the company, forward mail to owners, attend to
license renewals, corporate levies and related issues.
Company Name : OVERSEAS COMSEC LTD
Address : 2706
Suburb :
City :
![]()
SC is not known to have any subsidiary at
present.
![]()
PAYMENT RATING : 6 OBTAINED SCORES : No Data
|
Implication |
Implications |
|
|
1 |
Scores 85100 |
Excellent |
|
2 |
Scores 75 84 |
Above Average |
|
3 |
Scores 50 74 |
Average |
|
4 |
Scores 35 49 |
Fair |
|
5 |
Scores 15 34 |
Below Average |
|
6 |
Scores 01 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the payment
pattern of SC based upon our Payment Database, comments from suppliers of SC,
information from banks (if available), as well as industrial sources.
![]()
Under
*Bank Details*
============
Bank name : BANCAFE
INT'L
Branch :
![]()
Based on information on hand,
great caution is required in providing credit to SC & COD is
recommended.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SCs credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)